Characterizing the interaction modes of PAR4 receptor with agonist and antagonist by molecular simulation approach

被引:0
|
作者
Lu, Nan [1 ,2 ]
Meng, Fancui [2 ]
Yuan, Jing [2 ]
Liu, Lei [2 ]
Wang, Yanshi [2 ]
Li, Lingjun [2 ]
Zhao, Tong [2 ]
Xu, Weiren [2 ]
Tang, Lida [2 ]
Xu, Youjun [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Liaoning, Peoples R China
[2] Tianjin Inst Pharmaceut Res, Tianjin Key Lab Mol Design & Drug Discovery, Tianjin 300193, Peoples R China
来源
JOURNAL OF THEORETICAL & COMPUTATIONAL CHEMISTRY | 2019年 / 18卷 / 02期
关键词
PAR4; molecular docking; molecular dynamics; agonist; antagonist; PLATELET ACTIVATION; PROTEIN-STRUCTURE; IONIC LOCK; GENERATION; MECHANISM; EFFICIENT; PEPTIDE; BINDING;
D O I
10.1142/S0219633619500081
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Protease-activated receptor 4 (PAR4) is a promising target for antiplatelet therapy. In this study, homology modeling and molecular docking methods were used to investigate the binding modes of PAR4 agonists and antagonists. The outcomes show that agonists have good docking scores, and they also form more hydrogen bonds with PAR4 than antagonists. To reveal the different conformational changes caused by agonist and antagonist, molecular dynamic simulations were carried out on three selected PAR4 systems. Simulation results show that PAR4 activation involves breaking interactions of 3-7 lock switch (Try157 and Tyr322) and ionic lock switch (Arg188 and Asp173), and formation of transmission switch among Tyr161, Asn300 and Phe296. In addition, principal component analysis (PCA) indicates that the major change for agonist bound system takes place in the intracellular region while that for antagonist bound system is in the extracellular region. The binding free energy of BMS-986120 is much lower than AYPGKF, suggesting high affinity of antagonist. Moreover, the electronegative aspartic residues Asp230 and Asp235 at ECL2 are important for PAR4 binding to agonist. Clarifying the PAR4 structural characteristics may be helpful to understand the activation mechanism, giving insights into the molecular design and discovery of novel potential PAR4 antagonists in the future.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Platelet responsiveness to PAR4 activation in a healthy population and its inhibition by a potent and selective PAR4 antagonist
    Downes, K.
    Astle, W.
    McKinney, H.
    Kempster, C.
    Batista, J.
    Garner, S.
    Allegretto, N.
    Ouwehand, W. H.
    Yang, J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1017 - 1017
  • [2] Molecular cloning of the rat proteinase-activated receptor 4 (PAR4)
    Hoogerwerf, WA
    Hellmich, HL
    Micci, MA
    Winston, JH
    Zou, L
    Pasricha, PJ
    BMC MOLECULAR BIOLOGY, 2002, 3
  • [3] Human PAR4 Is a More Potent Receptor for Activating Platelets Than Mouse PAR4
    Renna, Stephanie
    Edelstein, Leonard C.
    McKenzie, Steven Edward
    BLOOD, 2019, 134
  • [4] Mapping the interaction of peptide RPPGF with the exodomain on human protease activated receptor 4 (PAR4).
    Nieman, MT
    Pagan-Ramos, E
    Warnock, M
    Krijanovski, Y
    Hasan, AAK
    Schmaier, AH
    BLOOD, 2004, 104 (11) : 511A - 512A
  • [5] Discovery of a first-in-class PAR4 antagonist as a novel antithrombotic
    Priestley, E.
    Banville, Jacques
    Callejo, Mario
    Deon, Daniel
    Dube, Laurence
    Gagnon, Marc
    Guarino, Victor
    Guy, Julia
    Guay, Jocelyne
    Harper, Timothy
    Lavallee, Jean-Francois
    Martel, Alain
    Posy, Shoshana
    Remillard, Roger
    Ruediger, Edward
    Tremblay, Francois
    Watson, Carol
    Wong, Pancras
    Bouvier, Michel
    Gordon, David
    Yang, Jing
    Wexler, Ruth
    Marinier, Anne
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [6] Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist
    Ma, L
    Hollenberg, MD
    Wallace, JL
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) : 701 - 704
  • [7] Agonist and antagonist recognition studies for oestrogen receptor by molecular dynamics simulation
    Li, Wen-Ming
    Li, Xiao-Bo
    Sun, Su-Xia
    Liang, Jing
    Wang, Run-Ling
    Wang, Shu-Qing
    MOLECULAR SIMULATION, 2013, 39 (03) : 228 - 233
  • [8] Interaction of thrombin with PAR1 and PAR4 at the thrombin cleavage site
    Nieman, Marvin T.
    Schmaier, Alvin H.
    BIOCHEMISTRY, 2007, 46 (29) : 8603 - 8610
  • [9] Protease-activated Receptor 1 (PAR1) and PAR4 Heterodimers Are Required for PAR1-enhanced Cleavage of PAR4 by α-Thrombin
    Arachiche, Amal
    Mumaw, Michele M.
    de la Fuente, Maria
    Nieman, Marvin T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (45) : 32553 - 32562
  • [10] Mapping the Protease Activated Receptor 4 (PAR4) Homodimer Interface
    Nieman, Marvin T.
    BLOOD, 2009, 114 (22) : 320 - 320